Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer Written by Petra Hegmann on 19th October 2020. Posted in Client News. [image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″] Previous Next
